Back to Authors
A5110745070 | I4405267392
Mayo Clinic
Kyverna Therapeutics, Inc. (United States)
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available
10.1212/wnl.0000000000217905